Senseera has closed a seed funding round, securing $7.1m to further develop its GEM BIOMARKERS liquid biopsy platform. Lightspeed Venture Partners led the financing round, with contributions from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback